Biotech Advisory vs Consultancy with David Cao, Founder of Target2Drug BioAdvisory
In this episode of Building Biotechs: A Podcast by Recruitomics Consulting, we’re joined by David Cao, Founder of Target2Drug BioAdvisory. Join us as we delve into the differences between biotech advisories and consultancies, and why working with startups is such a joyful experience!
Welcome to Building Biotechs: A Podcast by Recruitomics Consulting! Here, we offer a behind-the-scenes look into the strategy for launching and scaling successful biotech and life science companies.
Today, we chat with David Cao, Founder of Target2Drug BioAdvisory, an advisory firm dedicated to helping small biotechs make smarter and faster business and commercial strategic decisions. Prior to this, he was the VP of Commercial Strategy at Atomwise, and the Director of Global Analytics and Insights at Gilead Sciences.
Topics we Discuss:
- The difference between a biotech advisory and a consulting firm
- The joys of working with startups
- When to bring biotech advisors in
- How Target2Drug came to be
Subscribe here:
And connect with the hosts and guests here: